Roche Holding AG (RHHBY) est une société cotée en bourse dans le Santé secteur, opérant dans le Drug Manufacturers - General secteur d'activité. Le siège social de l'entreprise est situé à Basel, Switzerland. Le PDG actuel est Thomas Schinecker.
RHHBY a date d'introduction en bourse 2003-08-20, 103,249 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $328.42B.
Roche Holding AG is a Swiss multinational pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, immunology, cardiovascular and metabolism, ophthalmology, and respiratory diseases, as well as treatments for conditions such as cancer, hemophilia, and inflammatory disorders. In addition to pharmaceuticals, Roche operates a substantial diagnostics business offering in vitro tests for disease diagnosis including cancer, diabetes, COVID-19, and hepatitis, alongside diagnostic instruments and reagents. The company serves patients and healthcare providers across Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and numerous other markets globally.
